Navigation Links
Envoii Healthcare License Holder Private Access Inc. Receives TEPR Award
Date:2/4/2009

LEXINGTON, Ky., Feb. 4 /PRNewswire-FirstCall/ -- VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI) is proud to announce today that Private Access Inc., a licensee of the Envoii Healthcare STN application was recognized as The 2009 TEPR Awards Honoree for "Hot Product" for its PrivacyLayer, RecruitSource and TrialsFinder applications. The Hot product category recognizes the most innovative IT products that bring the most positive benefits or change to healthcare. Attracting decision makers internationally, the TEPR (Towards Electronic Patient Records) Conference is the premier health IT conference for clinicians, healthcare executives, and HIM and HIT professionals seeking the most innovative, cutting-edge and practical solutions for today's health IT issues.

In addition to having Private Access as a customer, VirtualHealth Technologies is an investor in the company as mentioned in its January 29th press release. "We are pleased to be affiliated with Private Access and are excited about their enormous potential in the health technology market," said Deborah Jenkins, VHGI board member. "Safeguarding privacy is an important factor to properly enable health information technology platforms. We believe that Private Access has an elegant and unique solution to transform communications in this marketplace." Ms. Jenkins also serves as a member of the board for Private Access, Inc. Additional information regarding the award can be found on Private Access' website at www.privateaccess.info

For additional information on Envoii Healthcare's System Tray Notifie application please go to http://www.virtualhealthtech.com/envoii.html

About VirtualHealth Technologies, Inc.

VirtualHealth Technologies, Inc. is committed to being the leader in the development and distribution of next generation solutions that connect healthcare providers to the rest of their community securely and efficiently. VirtualHealth's foundation is based on years of experience in providing highly sophisticated technology solutions to its existing medical customers and has branched out to include the pharmaceutical industry, as well as State and Federal Regulatory Agencies. VirtualHealth Technologies, Inc is headquartered in Lexington, Kentucky, with offices in Texas, Georgia and Florida. For more information, visit www.virtualhealthtechnologies.com

About Private Access, Inc.

Private Access, Inc. develops web-based applications that solve the significant privacy hurdles that the medical community faces when attempting to share confidential records in pursuit of faster diagnoses and better treatments for diseases and chronic illnesses. The company's vision is to leverage its method for individuals to establish and manage their dynamic electronic consent and its suite of solutions to transform the healthcare industry - creating a unique environment of trust for consumers and accelerating research at a considerably lower cost. Founded in 2006, Private Access is headquartered in Irvine, California and holds several patents covering its proprietary technology. For a product demo and more information, visit www.privateaccess.info

This press release contains forward-looking statements that reflect the Company's current expectations regarding future events. While these statements reflect the Company's best current judgment, they are subject to risks and uncertainties. Actual results may differ significantly from projected results due to a number of factors, including, but not limited to assumptions, beliefs and opinions relating to the business and growth strategy of VirtualHealth Technologies, Inc. and its wholly owned subsidiaries Verified Prescription Safeguards, Inc., VPS Holding, LLC, Envoii Healthcare, L.L.C., Medical Office Software, Inc. and implementation thereof, based upon the Company's interpretation and analysis of financial and market conditions, the decisions of businesses with whom the Company is either engaged in business with or negotiating, healthcare industry trends and management's ability to successfully finance, develop, market, sell and implement its e-commerce and internet solutions, clinical and financial e-transaction services and software applications to physicians, pharmacies, governmental agencies, laboratories, insurance companies, HMOs, and payers. These factors and other risk factors are more fully discussed in the Company's filings with the Securities and Exchange Commission. The Company expressly disclaims any intent or obligation to update any forward-looking statements.


    Contact: Shareholder Relations
             VirtualHealth Technologies, Inc.
             325 West Main Street, Suite 240
             Lexington, KY 40507
             (859) 455-9255
             Email: Shareholder.Relations@virtualhealthtechnologies.com
             Website: www.virtualhealthtechnologies.com


'/>"/>
SOURCE VirtualHealth Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ENVOII System Tray Notifier(TM) Demo Now Available Online
2. Podcast from Medialink, Bayer Healthcare LLC and WomenHeart: WomenHeart - Strong @Heart
3. Healthcare Realty Trust Announces Fourth Quarter Dividend
4. PWeR(TM) Introduced at Regional Healthcare Conference
5. Chindex International, Inc. to Participate in UBS Global Healthcare Services Conference
6. Nestle HealthCare Nutrition and Medical Professionals Unite to Improve Patient Safety
7. West Pharmaceutical Services To Present at the 2009 UBS Global Healthcare Services Conference
8. Community Voices: Healthcare for the Underserved Announces Second Annual Freedoms Voice Conference and Awards Gala
9. HMS Holdings Corp. to Present at 2009 UBS Global Healthcare Services Conference
10. Allscripts Survey of Healthcare Professionals Demonstrates Potential Impact of Economic Stimulus Plan on Electronic Health Record Adoption
11. Bayer Healthcare and WomenHeart Launch Strong @Heart Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... (PRWEB) , ... January 19, ... ... introducing the Aerolib Learning Management System: an On-demand E-learning system for Clinical ... and Hospital Administration that is based on Aerolib`s successful education methodology of ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... SF expansion and facility enhancement of their 503A compounding pharmacy located in Ocala, ... growing demand of physicians and patients throughout the United States for high-quality human ...
(Date:1/19/2017)... ... 2017 , ... This month, the CEO and Clinical Director of Sober Living ... center in Delray Beach, Florida has been changed from Sober Living Outpatient to ‘SLO ... Seymour Hoffman and Chris Farley are dying from heroin overdoses, but thousands of unnamed ...
(Date:1/19/2017)... ... 19, 2017 , ... WhoHaha , a digital media company dedicated to ... (AHA) to produce a three-part video series that uses humor to highlight ways to ... launch of AHA’s Healthy For Good™ movement, which is designed to inspire all Americans ...
(Date:1/19/2017)... ... 2017 , ... Cosmetic Town, an online plastic surgery community, begins 2017 with ... easier for their readers to get the information they desire. The procedures are now ... techniques used on those particular areas. , “We are excited to streamline our listings ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , , Marks E-QURE , ... agreement, following similar agreements in Israel and ... 5 billion global market ... leader in medical devices for the treatment of advanced wound care, announced today ... in Colombia for the Company,s patented Bio-electrical Signal Therapy ...
(Date:1/19/2017)... Jan. 18, 2017 The Global Therapy Partnering ... access to partnering deals and agreements entered into by ... partnering deals - Top deals by value - Deals ... technology type The report provides understanding and access ... the world,s leading healthcare companies. The report provides ...
(Date:1/19/2017)... , Jan. 18, 2017   Synthetic Biologics, ... company developing therapeutics designed to preserve the microbiome ... today confirmed plans to initiate a Phase 2b/3 ... reformulation of lovastatin lactone designed to reduce methane ... in the gut to treat the underlying cause ...
Breaking Medicine Technology: